The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications.
about
Inotropic agents and vasodilator strategies for acute myocardial infarction complicated by cardiogenic shock or low cardiac output syndromeInotropic agents and vasodilator strategies for acute myocardial infarction complicated by cardiogenic shock or low cardiac output syndromeStatins do not significantly affect muscle sympathetic nerve activity in humans with nonischemic heart failure: a double-blind placebo-controlled trialEmerging Novel Therapies for Heart FailureGene therapy for cardiovascular disease: advances in vector development, targeting, and delivery for clinical translationNon-pharmacological modulation of the autonomic tone to treat heart failureRole of the carotid body in the pathophysiology of heart failure'Ryanopathy': causes and manifestations of RyR2 dysfunction in heart failureCholinergic activity as a new target in diseases of the heartManaging therapeutic competition in patients with heart failure, lower urinary tract symptoms and incontinenceEmerging Concepts in the Molecular Basis of Pulmonary Arterial Hypertension: Part II: Neurohormonal Signaling Contributes to the Pulmonary Vascular and Right Ventricular Pathophenotype of Pulmonary Arterial HypertensionDiscrepant fibrinolytic response in plasma and whole blood during experimental endotoxemia in healthy volunteersRandomized controlled trial of relaxation music to reduce heart rate in patients undergoing cardiac CT.Neurocardiological differences between musicians and control subjects.Common genetic variation, residential proximity to traffic exposure, and left ventricular mass: the multi-ethnic study of atherosclerosis.Deletion of the β2-adrenergic receptor prevents the development of cardiomyopathy in mice.Effects of renal sympathetic denervation on post-myocardial infarction cardiac remodeling in rats.Obesity, Heart Failure, and Obesity ParadoxCorrelation of Ventricular Arrhythmogenesis with Neuronal Remodeling of Cardiac Postganglionic Parasympathetic Neurons in the Late Stage of Heart Failure after Myocardial InfarctionLOX-1 abrogation reduces cardiac hypertrophy and collagen accumulation following chronic ischemia in the mouseAcute myocardial infarction is associated with endothelial glycocalyx and cell damage and a parallel increase in circulating catecholamines.Nonlinear methods to assess changes in heart rate variability in type 2 diabetic patientsNuclear imaging in detection and monitoring of cardiotoxicity.Effect of educational program on quality of life of patients with heart failure: a randomized clinical trial.Nuclear localization of a1A-adrenergic receptors is required for signaling in cardiac myocytes: an “inside-out” a1-AR signaling pathway.Adrenergic receptor activation involves ATP release and feedback through purinergic receptors.Feasibility and safety of high-dose adenosine perfusion cardiovascular magnetic resonanceSex differences in β-adrenergic responsiveness of action potentials and intracellular calcium handling in isolated rabbit heartsEffects of thoracic epidural analgesia on plasma cAMP and cGMP levels in patients with heart failure.Renal sympathetic denervation inhibits the development of left ventricular mechanical dyssynchrony during the progression of heart failure in dogs.Making the case for skeletal myopathy as the major limitation of exercise capacity in heart failureIn vivo β-adrenergic receptor responsiveness: ethnic differences in the relationship with symptoms of depression and fatigueAlpha-1-adrenergic receptors: targets for agonist drugs to treat heart failure.Behavioral cross-sensitization between DOCA-induced sodium appetite and cocaine-induced locomotor behavior.Effects of stachydrine on norepinephrine-induced neonatal rat cardiac myocytes hypertrophy and intracellular calcium transients.Treatment of heart failure with preserved ejection fraction: have we been pursuing the wrong paradigm?Mitochondrial adaptations to physiological vs. pathological cardiac hypertrophy.The role of nuclear imaging in the failing heart: myocardial blood flow, sympathetic innervation, and future applications.Modulation of anthracycline-induced cardiotoxicity by aerobic exercise in breast cancer: current evidence and underlying mechanisms.Pathophysiology and the cardiorenal connection in heart failure. Circulating hormones: biomarkers or mediators.
P2860
Q24201225-98E9F2C8-50A8-422F-A7F9-AC90AE45E66FQ24203783-4293C817-766E-4E66-A3C9-2155081B93E8Q24632679-51287C6B-97F7-4796-846D-F0B38EB391CDQ26778111-614EB998-799C-44F4-A824-D9008A972335Q26799437-632CD596-14F1-4B62-A459-5DCDC86A2A16Q26822899-1213E128-83B4-463C-B175-929F3DD2645BQ26853502-D9D094C8-FF04-44BE-B4ED-828856AF6C71Q26865421-1175ADB1-53F0-4172-8A17-F9F38CB5BC6DQ27004543-9B123AEE-206A-418E-B54A-84CC878D5971Q27027072-39FBD2DE-3DB8-4367-8654-2AC0CED13A72Q28085007-C457BD70-461D-44FD-B4EF-CD6D3FA06C8BQ28488062-B4EE8B5E-E266-4650-AF8D-5BBEACC96A98Q30383926-9A57BB95-470A-44C8-89E8-81B703327CD6Q30425435-7CF121C2-83E7-4BDA-A9B6-5BCF62545E34Q30435119-CA35285A-3AB2-4670-B7D2-8316CE395644Q30548452-3A543A99-A3CB-4264-86D7-4D9080A021D9Q31103227-AA81B8FB-DB79-47E9-A16E-B3C4760AFBA5Q33617505-65A475D8-06CE-4773-8F69-E294234444BEQ33645818-7F04D5C9-6730-4797-9852-2A248DC6709DQ33709392-A1E073D2-B211-4DDE-9D98-2E33C3A1846CQ33753751-0475582C-1970-4E31-B8A0-3C476051EC6EQ33773337-846AF092-F9F0-42A8-9103-5F36BFB78374Q33942611-FD6A864D-C1C0-4C98-A7D2-E4974554D34EQ34164562-59B789D6-881F-4962-BD6C-DED229867526Q34297056-B5C5339B-A126-4C3C-B03E-CCD268E99334Q34304875-58582ADA-987E-4B0F-B80B-F71E06000E03Q34375525-7ACE2A20-E6CD-4326-8C3E-A205C8848F93Q34395874-9074F09A-B365-464C-A815-ACAD390C3AB3Q34461640-6727FAEA-C018-49E5-BA1B-22B6D3E1B860Q34632378-E9F04455-5085-4C20-9927-594DC32DD940Q34667465-99CDED8D-E258-453D-8218-5770267833C3Q34703424-71AFBCAF-64A4-4578-9CDA-9ED799363573Q34892203-CF5E91EE-38A1-4F38-99A6-C2E389DE872AQ34905514-F7B182A6-3D61-4503-8C6A-A89CA7ECF037Q34968150-8D2F8F1D-591D-410D-9C24-DF8BC4BCBFFDQ35016271-39779405-A589-490F-9598-E4F3F8316518Q35045900-206B824F-499F-4E4D-859D-CF1386BB2982Q35053611-51AB6D52-5451-452B-8A89-3AF827230F4AQ35158082-3405D184-31C4-42CB-80A3-3CA8E9A1AA8EQ35164124-D4393F00-73C2-47F1-9777-D38738B580BA
P2860
The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
The sympathetic nervous system ...... gy, and clinical implications.
@ast
The sympathetic nervous system ...... gy, and clinical implications.
@en
type
label
The sympathetic nervous system ...... gy, and clinical implications.
@ast
The sympathetic nervous system ...... gy, and clinical implications.
@en
prefLabel
The sympathetic nervous system ...... gy, and clinical implications.
@ast
The sympathetic nervous system ...... gy, and clinical implications.
@en
P2093
P1476
The sympathetic nervous system ...... gy, and clinical implications.
@en
P2093
Filippos Triposkiadis
George Karayannis
George Louridas
Grigorios Giamouzis
John Skoularigis
P304
P356
10.1016/J.JACC.2009.05.015
P407
P50
P577
2009-11-01T00:00:00Z